ALTRIA CLIENT SERVICES LLC for ALTRIA CLIENT SERVICES LLC
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
HR 2882 Further Consolidated Appropriations Act 2024; provisions related to regulation of tobacco, including enforcement efforts related to illegal e-cigarette and other unauthorized tobacco products HR 4368/S 2131 FY2024 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Bill; provisions related to enforcement efforts concerning illicit electronic nicotine delivery systems (ENDS) products and FDA rulemaking HR 4366 Consolidated Appropriations Act 2024; provisions related to regulation of tobacco, including tobacco product standards and enforcement efforts related to illegal e-cigarette and other unauthorized tobacco products
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANGELA ARBOLEDA | — |
| MICHELLE DIMAROB | — |
| CYNTHIA HAYDEN | — |
| JOHN HOEL | — |
| JENNIFER A KANE | — |
| JOHN MASON | — |
| PHIL PARK | — |
| JILIAN SOUZA | — |
| TODD WALKER | — |
Government Issues GOV
HR 6673 STATES 2.0 Act; all provisions of the bill S 2860 SAFER Banking Act; all provisions of the bill Discussions in support of the establishment of a comprehensive federal regulatory framework for cannabis Discussions concerning federal appropriations policy related to Food and Drug Administration clarity on CBD
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHELLE DIMAROB | — |
| PHIL PARK | — |
| JILIAN SOUZA | — |
| TODD WALKER | — |
Taxation/Internal Revenue Code TAX
Discussions concerning draft legislation to amend corporate tax rates Discussions concerning draft legislation on dividend tax rates Discussions regarding federal excise taxes on tobacco products Discussions concerning amendments to Section 958(b)(4) of the Internal Revenue Code Discussions concerning the full expensing of capital expenditures per the 2017 Tax Cuts & Jobs Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHELLE DIMAROB | — |
| CYNTHIA HAYDEN | — |
| JOHN HOEL | — |
| JENNIFER A KANE | — |
| JOHN MASON | — |
| PHIL PARK | — |
| JILIAN SOUZA | — |
| TODD WALKER | — |
Tobacco TOB
HR 901 Disposable ENDS Product Enforcement Act of 2023; all provisions of the bill ANPRM for Docket No. FDA-2017-N-6189 Implementation of P.L. 111-31 Family Smoking Prevention and Tobacco Control Act Implementation of P.L. 117-103 Consolidated Appropriations Act, 2022; provisions related to providing FDA authority to regulate products containing synthetic nicotine Discussions related to tobacco harm reduction Discussions concerning proposals to ban characterizing flavors in tobacco products FDA-2021-N-1309, Proposed Rule regarding Tobacco Product Standard for Characterizing Flavors in Cigars FDA-2021-N-1349, Proposed Rule regarding Tobacco Product Standard for Menthol in Cigarettes Discussions regarding the FDAs need to urgently implement a compliance and enforcement plan to address and prohibit the importation and sale of illicit flavored, disposable electronic nicotine delivery system (ENDS) products
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANGELA ARBOLEDA | — |
| MICHELLE DIMAROB | — |
| CYNTHIA HAYDEN | — |
| JOHN HOEL | — |
| JENNIFER A KANE | — |
| JOHN MASON | — |
| PHIL PARK | — |
| JILIAN SOUZA | — |
| TODD WALKER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.